FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288059025> ?p ?o ?g. }

• W4288059025 abstract "Longitudinal studies in HIV-1-infected individuals have indicated that 2 to 3 years of infection are required to develop broadly neutralizing antibodies. However, we have previously identified individuals with broadly neutralizing activity (bNA) in early HIV-1 infection, indicating that a vaccine may be capable of bNA induction after short periods of antigen exposure. Here, we describe 5 HIV-1 envelope sequences from individuals who have developed bNA within the first 100 days of infection (early neutralizers) and selected two of them to design immunogens based on HIV-1-Gag virus-like particles (VLPs). These VLPs were homogeneous and incorporated the corresponding envelopes (7 to 9 μg of gp120 in 1010 VLPs). Both envelopes (Envs) bound to well-characterized broadly neutralizing antibodies (bNAbs), including trimer-specific antibodies (PGT145, VRC01, and 35022). For immunogenicity testing, we immunized rabbits with the Env-VLPs or with the corresponding stabilized soluble envelope trimers. A short immunization protocol (105 days) was used to recapitulate the early nAb induction observed after HIV-1 infection in these two individuals. All VLP and trimeric envelope immunogens induced a comparably strong anti-gp120 response despite having immunized rabbits with 30 times less gp120 in the case of the Env-VLPs. In addition, animals immunized with VLP-formulated Envs induced antibodies that cross-recognized the corresponding soluble stabilized trimer and vice versa, even though no neutralizing activity was observed. Nevertheless, our data may provide a new platform of immunogens, based on HIV-1 envelopes from patients with early broadly neutralizing responses, with the potential to generate protective immune responses using vaccination protocols similar to those used in classical preventive vaccines. IMPORTANCE It is generally accepted that an effective HIV-1 vaccine should be able to induce broad-spectrum neutralizing antibodies. Since most of these antibodies require long periods of somatic maturation in vivo, several groups are developing immunogens, based on the HIV envelope protein, that require complex and lengthy immunization protocols that would be difficult to implement in the general population. Here, we show that rabbits immunized with new envelopes (VLP formulated) from two individuals who demonstrated broadly neutralizing activity very early after infection induced specific HIV-1 antibodies after a short immunization protocol. This evidence provides the basis for generating protective immune responses with classic vaccination protocols with vaccine prototypes based on HIV envelope sequences from individuals who have developed early broadly neutralizing responses." @default.
• W4288059025 created "2022-07-28" @default.
• W4288059025 creator A5002031212 @default.
• W4288059025 creator A5006647630 @default.
• W4288059025 creator A5014631807 @default.
• W4288059025 creator A5018245087 @default.
• W4288059025 creator A5041261266 @default.
• W4288059025 creator A5043369075 @default.
• W4288059025 creator A5045915262 @default.
• W4288059025 creator A5052923211 @default.
• W4288059025 creator A5060814796 @default.
• W4288059025 creator A5076488615 @default.
• W4288059025 creator A5087473572 @default.
• W4288059025 creator A5090367243 @default.
• W4288059025 date "2022-01-12" @default.
• W4288059025 modified "2023-10-18" @default.
• W4288059025 title "Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses" @default.
• W4288059025 cites W1127367459 @default.
• W4288059025 cites W1557243806 @default.
• W4288059025 cites W1635348995 @default.
• W4288059025 cites W1963406113 @default.
• W4288059025 cites W1965235265 @default.
• W4288059025 cites W1966351856 @default.
• W4288059025 cites W1968360645 @default.
• W4288059025 cites W1977476395 @default.
• W4288059025 cites W1982643583 @default.
• W4288059025 cites W2002844537 @default.
• W4288059025 cites W2004361534 @default.
• W4288059025 cites W2006712680 @default.
• W4288059025 cites W2008830902 @default.
• W4288059025 cites W2016582810 @default.
• W4288059025 cites W2021724381 @default.
• W4288059025 cites W2042430782 @default.
• W4288059025 cites W2046182783 @default.
• W4288059025 cites W2047426399 @default.
• W4288059025 cites W2048631685 @default.
• W4288059025 cites W2056420136 @default.
• W4288059025 cites W2074784570 @default.
• W4288059025 cites W2083002978 @default.
• W4288059025 cites W2084310667 @default.
• W4288059025 cites W2088005137 @default.
• W4288059025 cites W2093961711 @default.
• W4288059025 cites W2105903892 @default.
• W4288059025 cites W2115073288 @default.
• W4288059025 cites W2118820599 @default.
• W4288059025 cites W2120876680 @default.
• W4288059025 cites W2124307259 @default.
• W4288059025 cites W2126817706 @default.
• W4288059025 cites W2129515393 @default.
• W4288059025 cites W2135151522 @default.
• W4288059025 cites W2137939749 @default.
• W4288059025 cites W2153163225 @default.
• W4288059025 cites W2157272520 @default.
• W4288059025 cites W2159211452 @default.
• W4288059025 cites W2162802735 @default.
• W4288059025 cites W2166730438 @default.
• W4288059025 cites W2167861978 @default.
• W4288059025 cites W2169367715 @default.
• W4288059025 cites W2189898275 @default.
• W4288059025 cites W2199211191 @default.
• W4288059025 cites W2210879955 @default.
• W4288059025 cites W2240372320 @default.
• W4288059025 cites W2298966435 @default.
• W4288059025 cites W2325400389 @default.
• W4288059025 cites W2334437992 @default.
• W4288059025 cites W2470743131 @default.
• W4288059025 cites W2520562417 @default.
• W4288059025 cites W2550580379 @default.
• W4288059025 cites W2581517068 @default.
• W4288059025 cites W2581941486 @default.
• W4288059025 cites W2608004833 @default.
• W4288059025 cites W2721821765 @default.
• W4288059025 cites W2783088490 @default.
• W4288059025 cites W2791811398 @default.
• W4288059025 cites W2884366659 @default.
• W4288059025 cites W2892207493 @default.
• W4288059025 cites W2896671589 @default.
• W4288059025 cites W2905358223 @default.
• W4288059025 cites W2912400111 @default.
• W4288059025 cites W2946498544 @default.
• W4288059025 cites W2978621704 @default.
• W4288059025 cites W3032981172 @default.
• W4288059025 cites W3090798164 @default.
• W4288059025 doi "https://doi.org/10.1128/jvi.01343-21" @default.
• W4288059025 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34668778" @default.
• W4288059025 hasPublicationYear "2022" @default.
• W4288059025 type Work @default.
• W4288059025 citedByCount "9" @default.
• W4288059025 countsByYear W42880590252022 @default.
• W4288059025 countsByYear W42880590252023 @default.
• W4288059025 crossrefType "journal-article" @default.
• W4288059025 hasAuthorship W4288059025A5002031212 @default.
• W4288059025 hasAuthorship W4288059025A5006647630 @default.
• W4288059025 hasAuthorship W4288059025A5014631807 @default.
• W4288059025 hasAuthorship W4288059025A5018245087 @default.
• W4288059025 hasAuthorship W4288059025A5041261266 @default.
• W4288059025 hasAuthorship W4288059025A5043369075 @default.
• W4288059025 hasAuthorship W4288059025A5045915262 @default.
• W4288059025 hasAuthorship W4288059025A5052923211 @default.
• W4288059025 hasAuthorship W4288059025A5060814796 @default.

• next